Alexis E. Te

ORCID: 0000-0002-5815-7196
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Urinary Bladder and Prostate Research
  • Prostate Cancer Diagnosis and Treatment
  • Pelvic floor disorders treatments
  • Urological Disorders and Treatments
  • Hormonal and reproductive studies
  • Sexual function and dysfunction studies
  • Urologic and reproductive health conditions
  • Urinary Tract Infections Management
  • Prostate Cancer Treatment and Research
  • Anorectal Disease Treatments and Outcomes
  • Ureteral procedures and complications
  • Bladder and Urothelial Cancer Treatments
  • Sexual Differentiation and Disorders
  • Dermatologic Treatments and Research
  • Pharmacology and Obesity Treatment
  • Cardiovascular Syncope and Autonomic Disorders
  • Male Reproductive Health Studies
  • Surgical Simulation and Training
  • Pediatric Urology and Nephrology Studies
  • Peripheral Nerve Disorders
  • Renal and Vascular Pathologies
  • Reconstructive Surgery and Microvascular Techniques
  • Cardiac, Anesthesia and Surgical Outcomes
  • Genital Health and Disease
  • Urinary and Genital Oncology Studies

Cornell University
2016-2025

Weill Cornell Medicine
2017-2024

Presbyterian Hospital
2015-2024

Icahn School of Medicine at Mount Sinai
2018-2024

NewYork–Presbyterian Hospital
2007-2023

New York Hospital Queens
2006-2023

Penn Presbyterian Medical Center
2020-2023

Evidence (Italy)
2023

Michigan Department of Education
2023

American Urological Association
2023

We report the first multicenter randomized blinded trial of prostatic urethral lift for treatment lower urinary tract symptoms secondary to benign hyperplasia.Men at least 50 years old with AUASI (American Urological Association Symptom Index) 13 or greater, a maximum flow rate 12 ml per second less and prostate 30 80 cc were 2:1 between sham. In group small permanent implants are placed within retract encroaching lobes open urethra. Sham entailed rigid cystoscopy sounds mimicking lift. The...

10.1016/j.juro.2013.05.116 article EN The Journal of Urology 2013-06-11

We compared the safety and efficacy of Aquablation transurethral prostate resection for treatment lower urinary tract symptoms related to benign prostatic hyperplasia.In a double-blind, multicenter, prospective, randomized, controlled trial 181 patients with moderate severe hyperplasia underwent or Aquablation. The primary end point was reduction in International Prostate Symptom Score at 6 months. development Clavien-Dindo persistent grade 1, 2 higher operative complications.Mean total time...

10.1016/j.juro.2017.12.065 article EN The Journal of Urology 2018-01-31

No AccessJournal of UrologyClinical Urology: Original Article1 Feb 1995Urodynamic Findings in Patients With Diabetic Cystopathy Steven A. Kaplan, Alexis E. Te, Jerry G. Blaivas, and Edward J. McGuire KaplanSteven Kaplan , TeAlexis Te BlaivasJerry Blaivas McGuireEdward View All Author Informationhttps://doi.org/10.1097/00005392-199502000-00013AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail To ascertain the...

10.1097/00005392-199502000-00013 article EN The Journal of Urology 1995-02-01

No AccessJournal of UrologyAdult Urology: Voiding Dysfunction1 Oct 2004PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE FOR TREATMENT BENIGN PROSTATIC HYPERPLASIA: 12-MONTH RESULTS FROM FIRST UNITED STATES MULTICENTER PROSPECTIVE TRIAL ALEXIS E. TE, TERRENCE R. MALLOY, BARRY S. STEIN, JAMES C. ULCHAKER, UNYIME O. NSEYO, MAHMOOD A. HAI, and REZA MALEK TEALEXIS TE , MALLOYTERRENCE MALLOY STEINBARRY STEIN ULCHAKERJAMES ULCHAKER NSEYOUNYIME NSEYO HAIMAHMOOD HAI MALEKREZA View All Author...

10.1097/01.ju.0000139541.68542.f6 article EN The Journal of Urology 2004-09-15

We describe a novel technique of total vesico-urethral reconstruction, which combines the tactics previous surgeons, and compare outcome our innovative changes for return to early continence with prostatectomies no or partial reconstruction junction.Between 1 January 2005 5 June 2007 cohort 700 patients undergoing robotic radical prostatectomy were prospectively evaluated. Patients in (214) served as control group, they received additional methods provide support junction; standard...

10.1111/j.1464-410x.2008.07424.x article EN BJU International 2008-03-05

Prostate volume has been poorly correlated to various parameters used assess benign prostatic hyperplasia (BPH), including symptoms, peak urine flow and detrusor pressure at flow. The purpose of this study was 2-fold: 1) determine if transrectal ultrasound measurement the transition zone prostate served as a better proxy for determining size with American Urological Association symptom score, pressure, 2) parameter index (the ratio between volume) useful in evaluating clinical prostatism.We...

10.1016/s0022-5347(01)66779-x article EN The Journal of Urology 1995-11-01

Cystitis, or inflammation of the bladder, has a direct effect on bladder function. Interstitial cystitis is syndrome characterized by urinary pain and irritative symptoms more than 6 months duration. It commonly occurs in young to middle-aged women with no known cause fact represents diagnosis exclusion. Many factors have been suggested, including chronic subclinical infection, autoimmunity genetic susceptibility, which could be responsible for initiating inflammatory response. However,...

10.1177/1756287211398255 article EN Therapeutic Advances in Urology 2011-02-01

Background and Purpose: Photoselective laser vaporization prostatectomy (PVP) with a high-power KTP is hemostatic procedure for men symptomatic benign prostatic hyperplasia (BPH). This study demonstrates the feasibility of PVP in who are receiving anticoagulants. Patients Methods: Men treated BPH between July 2002 September 2003 were anticoagulants (N = 24) reviewed retrospectively. Their mean age was 75 years, prostate volume 82 cc (range 34-164 cc). Nine (38%) retention, eight (33%) had...

10.1089/end.2005.19.1196 article EN Journal of Endourology 2005-12-01

In this open label, prospective study we determined the efficacy and tolerability of tolterodine extended release (ER) in men with benign prostatic hyperplasia (BPH) lower urinary tract symptoms (LUTS) whom previous alpha-blocker therapy had failed.A total 43 consecutive BPH LUTS a mean 5.7 months failed due to adverse events (11) or lack (32) received ER (4 mg daily) for 6 months. Primary end points were American Urological Association symptom score, daytime nighttime micturition frequency....

10.1097/01.ju.0000181823.33224.a0 article EN The Journal of Urology 2005-11-03

Study Type – Prognosis (cohort) Level of Evidence 2a What's known on the subject? and What does study add? The metabolic syndrome, or Syndrome X, has traditionally been associated with an increased risk cardiovascular disease sexual dysfunction. Emerging data however now suggest that syndrome may also have a heretofore unrecognized negative effect voiding function as well. Weight loss through either behavioural modification bariatric surgery shown to lead improvement in stress urge...

10.1111/j.1464-410x.2011.10819.x article EN BJU International 2012-01-13

In a multicentre study from the USA, 3-year results of high-power KTP laser prostatectomy are presented. The authors used preoperative PSA level as marker prostate volume and assessed its potential predictive value on clinical efficacy for treating symptomatic BPH. They found that overall technique were positive durable, suggested there was significant difference in between patients presenting with total <6 or >6 ng/mL. Many who have had radical followed prolonged period several observations...

10.1111/j.1464-410x.2006.06197.x article EN BJU International 2006-05-09

Many patients are misdiagnosed as having refractory chronic nonbacterial prostatitis, and treated with antibiotics and/or alpha-blockers variable success. This study was designed to ascertain the potential diagnostic role of synchronous video-pressure-flow urodynamics therapeutic transurethral incision bladder neck in 34 consecutive men (age 26 51 years) a minimum 2 years misdiagnosis. Duration symptoms ranged from 25 126 months (mean 38.3). The average number previous antibiotic days 42 136...

10.1016/s0022-5347(17)32309-1 article EN The Journal of Urology 1994-12-01

No AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Jan 2004A Prospective, 1-Year Trial Using Saw Palmetto Versus Finasteride in the Treatment Category III Prostatitis/Chronic Pelvic Pain Syndrome STEVEN A. KAPLAN, MICHAEL VOLPE, and ALEXIS E. TE KAPLANSTEVEN KAPLAN , VOLPEMICHAEL VOLPE TEALEXIS View All Author Informationhttps://doi.org/10.1097/01.ju.0000101487.83730.80AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked...

10.1097/01.ju.0000101487.83730.80 article EN The Journal of Urology 2004-01-01

Objective: We evaluated 5-year safety, efficacy and prostate volume data from BPH patients treated with finasteride or dutasteride. Methods: A retrospective analysis of 378 consecutive men 5α-reductase inhibitor monotherapy between January 2004 September 2009 (197 on 211 dutasteride) in a single clinic was performed. Efficacy assessments included International Prostate Symptom Score (IPSS), peak urinary flow rate (Qmax), postvoid residual urine (PVR), prostate-specific antigen (PSA) (PV)....

10.1111/j.1742-1241.2012.03010.x article EN International Journal of Clinical Practice 2012-10-16
Coming Soon ...